Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 11/20 | 0.60 |
| ▸ | ITGA2B | P08514 | 7/20 | 0.60 |
| ▸ | ITGAV | P06756 | 6/20 | 0.53 |
| ▸ | ITGB5 | P18084 | 4/20 | 0.53 |
| ▸ | ITGB6 | P18564 | 4/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | ITGB8 | P26012 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.45 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5700867 | 1.00 | ITGB3 (0.60) | ITGB3ITGA2BITGAVITGB5ITGB6 | |
| SCHEMBL9829985 | 0.88 | SMN1; SMN2 (0.57) | ITGB3ITGA2BITGAVITGB5ITGB6 | |
| SCHEMBL27758299 | 0.86 | ASAH1 (0.60) | ITGB3ITGA2BITGAVITGB5ITGB6 | |
| SCHEMBL9829245 | 0.84 | SMN1; SMN2 (0.60) | ITGB3ITGA2BITGAVITGB5ITGB6 | |
| SCHEMBL6827881 | 0.83 | ITGB3 (0.62) | ITGB3ITGA2BSMN1; SMN2ALDH1A1HTT | |
| SCHEMBL9844424 | 0.81 | NPSR1 (0.56) | ALDH1A1 | |
| SCHEMBL6857593 | 0.81 | SMN1; SMN2 (0.64) | ITGB3ITGA2BITGAVITGB5ITGB6 | |
| SCHEMBL13702523 | 0.80 | ITGB3 (0.52) | ITGB3ITGA2BITGAVITGB5ITGB6 | |
| SCHEMBL13702524 | 0.80 | ITGB3 (0.52) | ITGB3ITGA2BITGAVITGB5ITGB6 | |
| SCHEMBL6355786 | 0.80 | ALDH1A1 (0.69) | ITGB3ITGA2BITGAVITGB5ITGB6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1027328-B1 | SUBSTITUTED ANILIDES | AVENTIS PHARMA LTD (GB) | 2006-08-23 | — | — | EP | disclosed |
| US-6479519-B1 | INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE | AVENTIS PHARMA LIMITED (GB) | 2002-11-12 | — | — | US | disclosed |
| CN-1327443-A | Substituted anilide compounds | ARVENTIS PHARMACEUTICALS CO LT (GB) | 2001-12-19 | — | — | CN | disclosed |